StockData
Contineum Therapeutics, Inc. logo

Contineum Therapeutics, Inc. (CTNM) stock

CTNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30
$9.24−0.31 (-3.25%)

Close on Nov 18, 2026Market cap $347.62MP/E –Yield –

Contineum Therapeutics cash

Cash and short-term investments held at the end of each period.

Contineum Therapeutics's cash was $236.60M at Jun 30, 2026. For fiscal 2025 it was $262.90M, up 28.4% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$262.90M+28.4%
FY2024Dec 31, 2024$204.80M+63.6%
FY2023Dec 31, 2023$125.19M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$236.60M+34.8%
Q1 FY2026Mar 31, 2026$246.30M+29.2%
Q4 FY2025Dec 31, 2025$262.90M+28.4%
Q3 FY2025Sep 30, 2025$182.40M-14.7%
Q2 FY2025Jun 30, 2025$175.50M-19.8%
Q1 FY2025Mar 31, 2025$190.70M+61.7%
Q4 FY2024Dec 31, 2024$204.80M+63.6%
Q3 FY2024Sep 30, 2024$213.90M–
Q2 FY2024Jun 30, 2024$218.70M–
Q1 FY2024Mar 31, 2024$117.90M–
Q4 FY2023Dec 31, 2023$125.19M–

More Contineum Therapeutics figures

See a number that looks wrong?